Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Biochem Biophys Res Commun ; 403(3-4): 345-50, 2010 Dec 17.
Article in English | MEDLINE | ID: mdl-21078294

ABSTRACT

The effects of concomitant use of fibroblast growth factor-2 (FGF-2) and beta-tricalcium phosphate (ß-TCP) on periodontal regeneration were investigated in the beagle dog 1-wall periodontal defect model. One-wall periodontal defects were created in the mesial portion of both sides of the mandibular first molars, and 0.3% FGF-2 plus ß-TCP or ß-TCP alone was administered. Radiographic evaluation was performed at 0, 3, and 6 weeks. At 6 weeks, the periodontium with the defect site was removed and histologically analyzed. Radiographic findings showed that co-administration of FGF-2 significantly increased bone mineral contents of the defect sites compared with ß-TCP alone. Histologic analysis revealed that the length of the regenerated periodontal ligament, the cementum, distance to the junctional epithelium, new bone height, and area of newly formed bone were significantly increased in the FGF-2 group. No abnormal inflammatory response or ankylosis was observed in either group. These findings indicate the efficacy of concomitant use of FGF-2 and ß-TCP as an osteoconductive material for periodontal regeneration following severe destruction by progressive periodontitis.


Subject(s)
Calcium Phosphates/administration & dosage , Fibroblast Growth Factor 2/administration & dosage , Periodontitis/drug therapy , Periodontium/drug effects , Periodontium/physiology , Regeneration/drug effects , Animals , Disease Models, Animal , Dogs , Female , Periodontitis/pathology , Periodontium/pathology
2.
J Biomed Mater Res A ; 74(3): 374-80, 2005 Sep 01.
Article in English | MEDLINE | ID: mdl-15973728

ABSTRACT

Fibroblast growth factor-2 (FGF-2) participates in the morphological transformation of astrocytes (stellation) during the formation of glial scars in injured brains. In the current study, we used quantitative morphometric analysis to investigate the structural requirements for heparin's enhancement of FGF-2-induced stellation of cultured cortical astrocytes. Native heparin significantly promoted FGF-2-dependent astrocytic stellation, whereas heparin hexasaccharide inhibited FGF-2-dependent stellation. Furthermore, 2-O-, 6-O-, and N-desulfated heparins were unable to promote FGF-2-dependent stellation. The stellation induced by FGF-2 or by a combination of FGF-2 and native heparin was inhibited by SU5402, an FGF receptor inhibitor. These results demonstrate that the length and sulfated position of heparin are important for its enhancement of FGF-2-dependent astrocyte stellation. In addition, our findings show that heparin oligosaccharides are useful for regulating the FGF-2-dependent astrocytic transformation.


Subject(s)
Astrocytes/drug effects , Cell Shape/physiology , Fibroblast Growth Factor 2/physiology , Heparin/pharmacology , Animals , Astrocytes/cytology , Astrocytes/metabolism , Cells, Cultured , Dose-Response Relationship, Drug , Rats , Rats, Wistar , Swine
SELECTION OF CITATIONS
SEARCH DETAIL